A 4-year longitudinal study of 555 patients treated with ranibizumab for neovascular age-related macular degeneration

Annette Rasmussen, Sara B Bloch, Josefine Fuchs, Louise Kim Hillerup Hansen, Michael Larsen, Morten Dornonville de la Cour, Henrik Lund-Andersen, Birgit Sander

100 Citationer (Scopus)

Abstract

To investigate the visual outcome, pattern of discontinuation, ocular complications, and mortality of patients treated with a variable ranibizumab dosing regimen for neovascular age-related macular degeneration (AMD) for 4 years.
OriginalsprogEngelsk
TidsskriftOphthalmology
Vol/bind120
Udgave nummer12
Sider (fra-til)2630-6
Antal sider7
ISSN0161-6420
DOI
StatusUdgivet - dec. 2013

Fingeraftryk

Dyk ned i forskningsemnerne om 'A 4-year longitudinal study of 555 patients treated with ranibizumab for neovascular age-related macular degeneration'. Sammen danner de et unikt fingeraftryk.

Citationsformater